AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
Cytomegalovirus pneumonia in adults with leukemia: An emerging problem
Authors: Nguyen, Q Estey, E Raad, I Rolston, K Kantarjian, H Jacobson, K Konoplev, S Ghosh, S Luna, M Tarrand, J Whimbey, E
Citation: Q. Nguyen et al., Cytomegalovirus pneumonia in adults with leukemia: An emerging problem, CLIN INF D, 32(4), 2001, pp. 539-545
Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acid
Authors: Estey, E Koller, C Cortes, J Reed, P Freireich, E Giles, F Kantarjian, H
Citation: E. Estey et al., Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acid, LEUK LYMPH, 42(3), 2001, pp. 309-316
High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome
Authors: Verstovsek, S Estey, E Manshouri, T Keating, M Kantarjian, H Giles, FJ Albitar, M
Citation: S. Verstovsek et al., High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome, LEUK LYMPH, 42(3), 2001, pp. 511-516
Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long term survival
Authors: Giles, FJ Shen, Y Kantarjian, HM Korbling, MJ O'Brien, S Anderlini, P Donato, M Pierce, S Keating, MJ Freireich, EJ Estey, E
Citation: Fj. Giles et al., Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long term survival, LEUK LYMPH, 42(1-2), 2001, pp. 67-73
Comparison of amphotericin B lipid complex (ABLC) vs. AmBisome in the treatment of suspected or documented fungal infections in patients with leukemia
Authors: Fleming, RV Kantarjian, HM Husni, R Rolston, K Lim, J Raad, I Pierce, S Cortes, J Estey, E
Citation: Rv. Fleming et al., Comparison of amphotericin B lipid complex (ABLC) vs. AmBisome in the treatment of suspected or documented fungal infections in patients with leukemia, LEUK LYMPH, 40(5-6), 2001, pp. 511-520
Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome
Authors: Verstovsek, S Kantarjian, H Estey, E Aguayo, A Giles, FJ Manshouri, T Koller, C Estrov, Z Freireich, E Keating, M Albitar, M
Citation: S. Verstovsek et al., Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome, LEUKEMIA, 15(8), 2001, pp. 1165-1170
Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing
Authors: Sarriera, JE Albitar, M Estrov, Z Gidel, C Aboul-Nasr, R Manshouri, T Kornblau, S Chang, KS Kantarjian, H Estey, E
Citation: Je. Sarriera et al., Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing, LEUKEMIA, 15(1), 2001, pp. 57-61
Highly reproducible detection and semi-quantification of telomerase activity
Authors: Verstovsek, S Manshouri, T Kantarjian, H Giles, FJ Keating, M Estey, E Albitar, M
Citation: S. Verstovsek et al., Highly reproducible detection and semi-quantification of telomerase activity, BIOTECHNIQU, 30(5), 2001, pp. 930
Classifying chronic myelomonocytic leukemia - In Reply
Authors: Greenberg, P Anderson, J Estey, E Fenaux, P Hamblin, T Hellstrom-Lindberg, E List, A Ohyashiki, K Sanz, G Zanz, M
Citation: P. Greenberg et al., Classifying chronic myelomonocytic leukemia - In Reply, J CL ONCOL, 19(17), 2001, pp. 3791-3792
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse
Authors: Sievers, EL Larson, RA Stadtmauer, EA Estey, E Lowenberg, B Dombret, H Karanes, C Theobald, M Bennett, JM Sherman, ML Berger, MS Eten, CB Loken, MR van Dongen, JJM Bernstein, ID Appelbaum, FR
Citation: El. Sievers et al., Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse, J CL ONCOL, 19(13), 2001, pp. 3244-3254
Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia
Authors: Giles, F Cortes, J Garcia-Manero, G Kornblau, S Estey, E Kwari, M Murgo, A Kantarjian, H
Citation: F. Giles et al., Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia, INV NEW DR, 19(1), 2001, pp. 13-20
Reducing mortality associated with immediate treatment complications of adult leukemias
Authors: Estey, E
Citation: E. Estey, Reducing mortality associated with immediate treatment complications of adult leukemias, SEM HEMATOL, 38(4), 2001, pp. 32-37
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.
Authors: Milella, M Kornblau, SM Estrov, Z Carter, BZ Lapillonne, H Harris, D Konopleva, M Zhao, SR Estey, E Andreeff, M
Citation: M. Milella et al., Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia., J CLIN INV, 108(6), 2001, pp. 851-859
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia
Authors: Cortes, J Estey, E O'Brien, S Giles, F Shen, Y Koller, C Beran, M Thomas, D Keating, M Kantarjian, H
Citation: J. Cortes et al., High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia, CANCER, 92(1), 2001, pp. 7-14
Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome
Authors: Verstovsek, S Kantarjian, H Aguayo, A Manshouri, T Freireich, E Keating, M Estey, E Albitar, M
Citation: S. Verstovsek et al., Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome, BR J HAEM, 114(2), 2001, pp. 290-295
Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid
Authors: Douer, D Estey, E Santillana, S Bennett, JM Lopez-Bernstein, G Boehm, K Williams, T
Citation: D. Douer et al., Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid, BLOOD, 97(1), 2001, pp. 73-80
AML in the elderly
Authors: Estey, E Cortes, J Beran, M Koller, CA Keating, MJ
Citation: E. Estey et al., AML in the elderly, HEMAT BLOOD, 40, 2001, pp. 621-627
Cyclophosphamide, ara-C and topotecan (CAT) for patients with refractory or relapsed acute leukemia
Authors: Cortes, J Estey, E Beran, M O'Brien, S Giles, F Koller, C Keating, M Kantarjian, H
Citation: J. Cortes et al., Cyclophosphamide, ara-C and topotecan (CAT) for patients with refractory or relapsed acute leukemia, LEUK LYMPH, 36(5-6), 2000, pp. 479-484
NCCN Practice Guidelines for acute myelogenous leukemia
Authors: O'Donnell, MR Appelbaum, FR Baer, MR Carabasi, MH Coutre, SE Erba, HP Estey, E Glenn, MJ Kraut, EH Maslak, P Millenson, M Miller, CB Saba, HI Stone, R Tallman, MS
Citation: Mr. O'Donnell et al., NCCN Practice Guidelines for acute myelogenous leukemia, ONCOLOGY-NY, 14(11A), 2000, pp. 53-61
Problematic WHO reclassification of myelodysplastic syndromes
Authors: Greenberg, P Anderson, J de Witte, T Estey, E Fenaux, P Gupta, P Hamblin, T Hellstrom-Lindberg, E List, A Mufti, G Neuwirtova, R Ohyashiki, K Oscier, D Sanz, G Sanz, M Willman, C
Citation: P. Greenberg et al., Problematic WHO reclassification of myelodysplastic syndromes, J CL ONCOL, 18(19), 2000, pp. 3447-3449
Increased CD38 expression is associated with favorable prognosis in adult acute leukemia
Authors: Keyhani, A Huh, YO Jendiroba, D Pagliaro, L Cortez, J Pierce, S Pearlman, M Estey, E Kantarjian, H Freireich, EJ
Citation: A. Keyhani et al., Increased CD38 expression is associated with favorable prognosis in adult acute leukemia, LEUK RES, 24(2), 2000, pp. 153-159
The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia
Authors: Faderl, S Kantarjian, HM Estey, E Manshouri, T Chan, CY Elsaied, AR Kornblau, SM Cortes, J Thomas, DA Pierce, S Keating, MJ Estrov, Z Albitar, M
Citation: S. Faderl et al., The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia, CANCER, 89(9), 2000, pp. 1976-1982
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
Authors: Aguayo, A Kantarjian, H Manshouri, T Gidel, C Estey, E Thomas, D Koller, C Estrov, Z O'Brien, S Keating, M Freireich, E Albitar, M
Citation: A. Aguayo et al., Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes, BLOOD, 96(6), 2000, pp. 2240-2245
Differences between refractory anemia with excess blasts in transformationand acute myeloid leukemia
Authors: Albitar, M Beran, M O'Brien, S Kantarjian, H Frieriech, E Keating, M Estey, E
Citation: M. Albitar et al., Differences between refractory anemia with excess blasts in transformationand acute myeloid leukemia, BLOOD, 96(1), 2000, pp. 372-373
The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics
Authors: Kornblau, SM Thall, PF Estrov, Z Walterscheid, M Patel, S Theriault, A Keating, MJ Kantarjian, H Estey, E Andreeff, M
Citation: Sm. Kornblau et al., The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics, CLIN CANC R, 5(7), 1999, pp. 1758-1766
Risultati: 1-25 | 26-38